Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
Multidrug-resistant (MDR) tuberculosis (TB) is a threat to global TB control, as suboptimal and poorly tolerated treatment options have resulted in largely unfavourable outcomes for these patients. The last of six cohort studies conducted in Bangladesh which assessed a new shorter regimen using curr...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2016-03-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/25/139/29.full |